Novartis
NVS
NVS
1,136 hedge funds and large institutions have $18.6B invested in Novartis in 2021 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 417 increasing their positions, 444 reducing their positions, and 101 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
13% less capital invested
Capital invested by funds: $21.5B → $18.6B (-$2.88B)
29% less first-time investments, than exits
New positions opened: 72 | Existing positions closed: 101
71% less funds holding in top 10
Funds holding in top 10: 14 → 4 (-10)
Holders
1,136
Holding in Top 10
4
Calls
$239M
Puts
$124M
Top Buyers
| 1 | +$186M | |
| 2 | +$95.2M | |
| 3 | +$83.6M | |
| 4 |
Aristotle Capital Management
Los Angeles,
California
|
+$70.9M |
| 5 |
BlackRock
New York
|
+$50M |
Top Sellers
| 1 | -$214M | |
| 2 | -$174M | |
| 3 | -$153M | |
| 4 |
ClearBridge Investments
New York
|
-$138M |
| 5 |
Primecap Management
Pasadena,
California
|
-$113M |